Association of molecular subtypes and treatment with survival in invasive micropapillary breast cancer: an analysis of the Surveillance, Epidemiology, and End Results database

CONCLUSION: The prognosis of IMPC was significantly influenced by different molecular subtypes. Chemotherapy and radiotherapy are beneficial in HR+/HER2+ and HR+/HER2- patients. However, they should be used with caution in HR-/HER2- (TN) patients.PMID:38043116 | DOI:10.1007/s12282-023-01523-9

Source: Breast Cancer - December 3, 2023 Category: Cancer & Oncology Authors: Zhenning Tang Ling Li Xiaoying Huang Yinbing Zhao Lingyan Huang Source Type: research